oxaliplatin
Generic: oxaliplatin
Labeler: qilu pharmaceutical co., ltd.Drug Facts
Product Profile
Brand Name
oxaliplatin
Generic Name
oxaliplatin
Labeler
qilu pharmaceutical co., ltd.
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
Active Ingredients
oxaliplatin 50 mg/10mL
Manufacturer
Identifiers & Regulatory
Product NDC
67184-0501
Product ID
67184-0501_f9f54aa0-22e3-4958-b368-d89d716ac2fa
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA204616
Listing Expiration
2026-12-31
Marketing Start
2016-05-11
Pharmacologic Class
Established (EPC)
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
671840501
Hyphenated Format
67184-0501
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
oxaliplatin (source: ndc)
Generic Name
oxaliplatin (source: ndc)
Application Number
ANDA204616 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 50 mg/10mL
Packaging
- 1 VIAL, SINGLE-DOSE in 1 CARTON (67184-0501-1) / 10 mL in 1 VIAL, SINGLE-DOSE
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "f9f54aa0-22e3-4958-b368-d89d716ac2fa", "openfda": {"nui": ["N0000175413", "N0000175073"], "upc": ["0367184050116", "0367184050215"], "unii": ["04ZR38536J"], "rxcui": ["1736784", "1736786"], "spl_set_id": ["e9e47f3c-9acc-44f5-b0bd-d26fe9d35d64"], "pharm_class_epc": ["Platinum-based Drug [EPC]"], "manufacturer_name": ["Qilu Pharmaceutical Co., Ltd."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (67184-0501-1) / 10 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "67184-0501-1", "marketing_start_date": "20160511"}], "brand_name": "Oxaliplatin", "product_id": "67184-0501_f9f54aa0-22e3-4958-b368-d89d716ac2fa", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Platinum-based Drug [EPC]", "Platinum-containing Compounds [EXT]"], "product_ndc": "67184-0501", "generic_name": "Oxaliplatin", "labeler_name": "Qilu Pharmaceutical Co., Ltd.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Oxaliplatin", "active_ingredients": [{"name": "OXALIPLATIN", "strength": "50 mg/10mL"}], "application_number": "ANDA204616", "marketing_category": "ANDA", "marketing_start_date": "20160511", "listing_expiration_date": "20261231"}